{"name":"Life for a Child Program, Diabetes Australia","slug":"life-for-a-child-program-diabetes-australia","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"biosimilar insulin glargine","genericName":"biosimilar insulin glargine","slug":"biosimilar-insulin-glargine","indication":"Type 1 diabetes mellitus","status":"marketed"}]}],"pipeline":[{"name":"biosimilar insulin glargine","genericName":"biosimilar insulin glargine","slug":"biosimilar-insulin-glargine","phase":"marketed","mechanism":"Biosimilar insulin glargine is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and lower blood glucose levels.","indications":["Type 1 diabetes mellitus","Type 2 diabetes mellitus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQM3A0TlI5RExDdnBENVR4dEM1MlFaSlMyb2Q0emFva216VV9BWWtXSmhmcUVxRGNaTUp3VGc0ODNsOVJSZnotNXZmWFNsdzlQYk5IalJxc0dtM2twd0FOQnZkelVIMWRjNVIwa2lhSHlJV191UlJuNE5GSlRCWmVsbG5PZHV6RUdyMlNSUm9tME1vZWRlYTZ0MkFRREV5WG1QcFhQbzB3?oc=5","date":"2025-04-28","type":"pipeline","source":"Australian Broadcasting Corporation","summary":"Mum says new diabetes drug would be 'kind of magic' if it works - Australian Broadcasting Corporation","headline":"Mum says new diabetes drug would be 'kind of magic' if it works","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-06","type":"pipeline","source":"The Times of India","summary":"$78 million reward on Elon Musk's head for diabetes cure, Facebook scam claims - The Times of India","headline":"$78 million reward on Elon Musk's head for diabetes cure, Facebook scam claims","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVTlqZVFaaGx0UTRhMWlsSWRBeWJ2QnQ1Ym81TzdnamkwS2FMbGtSRjV2OHVQSHF4N2NjdlNBMHpGZjNnMGhFYl9Ic2hoZmdHT1YyMVJobXRKV1ZIOENUeU1WOGtLTm1EZHJjbDdMVjhUOThja3lpbDFfWDdhaHZMbmlWeGowRFI5ZlA5OUN3a0NGNjgzd0VJUEp6UEdRUGc0UWJrRFdCX3hVd1h1c2d5Y1dFT1ktMVpi?oc=5","date":"2023-09-26","type":"pipeline","source":"BioPharma APAC","summary":"RSSDI-Sanofi Type 1 Diabetes Program Yields Positive Results in India - BioPharma APAC","headline":"RSSDI-Sanofi Type 1 Diabetes Program Yields Positive Results in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9fSWI5NmVPYk5Ibl9Xdk85RzNDSllLTGhxRExwWDJEVlZSYkRfN01uT0pKSmx3YVQxZDFrdnVCcjNwUTNtaHZKQWNPaERNd0VCaHBBMEFQRklBUVE?oc=5","date":"2022-12-07","type":"pipeline","source":"Diabetes Australia","summary":"Campaigns - Diabetes Australia","headline":"Campaigns","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPXzBZM3lkUnpRU2w1enhWQWhUWm9TZ19aei0xR0hZZTc2ZjJzVXR2TTVtaEpqUnV5aXl3OVJUMEJndDBjMlZNdlJySXFGd0dMU0ZPdkFWNVVGMlROTmtLa2FZajNacDNpOVlNR1VUcFhtTG5Kdk1VX2FVQ3RVbnE3YU1UdFdUTkI4QmdxTDhOLUpMNkFWOEpicw?oc=5","date":"2021-12-10","type":"pipeline","source":"Royal Australian College of General Practitioners (RACGP)","summary":"Rare diseases are a ‘common’ problem for clinicians - Royal Australian College of General Practitioners (RACGP)","headline":"Rare diseases are a ‘common’ problem for clinicians - Royal Australian College of General Practitioners (RACGP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxPeDVIV2l6U3RPbWhkZXpBOWRLQ3VUdS05QV83SUN5OUxCWDhVTW1RWmVSR2lPTldvLW9mcmdQS19qUnRZd2E4UXNxS1Z0WlYxSGxHYTdYd1l1RnZBYzlESXlIaFVBaVZ1QUFNbHdia3lpdUJUUFR0SlY2ZDlGYVZNcDUwNkVxRmZXX3BLd2FxaDlLczdMX293QTFLRUEtamwwWjlaSkE3bDBxc1FVSmVDbThtaW1oWUNBZG0yZDFKQUl0ZmNXN2VyN1BWWkE3ZlljT3h2NlFaMFV3MXZ2VzRxRjh6NUt1TzJ6N2RzS2NHcmF2enB2ZEF1THBFblQ0d0hj?oc=5","date":"2021-01-28","type":"deal","source":"PR Newswire","summary":"Lilly, Life for a Child and Beyond Type 1 advance partnership to improve diabetes care in resource-limited countries - PR Newswire","headline":"Lilly, Life for a Child and Beyond Type 1 advance partnership to improve diabetes care in resource-limited countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBQSkZHWnc1UGpUMmVqSmp6WWZfN3V4Z2tIVjZuQXVadjVwLWJQdW02YmpucDJCN2ItQ0NPNGdnTHIxWXhiVm9qeG9HNDZLQnZWZ0t6TElnWQ?oc=5","date":"2018-06-06","type":"pipeline","source":"Direct Relief","summary":"Diabetes Care - Direct Relief","headline":"Diabetes Care","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}